Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0002028640-26-000007

Director sold 325 shares at $550.59 ($178,942)

  • Director acquired 650 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MALCOLM JAN · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-09 Exercise or conversion : show line 1 in the form 10b5-1 +650 775 D
2026-07-10 Sale : show line 2 in the form 10b5-1 −325 $550.59 $178,942 450 D
Open-market sales · 325 sh · avg $550.59 · $178,942

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-09 Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Unit −650 0 D
Loading xslF345X06/primarydocument.xml…